Citation Impact
Citing Papers
Projection of an Immunological Self Shadow Within the Thymus by the Aire Protein
2002 StandoutScience
Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer.
1990
HER-2/neu Amplification Is an Independent Prognostic Factor in Gastric Cancer
2006
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
2010 Standout
The role of HER2 in angiogenesis
2001
A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF- B and enhanced IRF-3/STAT1 activation)
2005
EGFR Antagonists in Cancer Treatment
2008 Standout
Inflammation and cancer
2002 StandoutNature
Comparing antibody and small-molecule therapies for cancer
2006
Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer
2003 Standout
Tumor necrosis factor, cancer and anticancer therapy
2004
Gold nanoparticles in delivery applications☆
2008 Standout
Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells
1993 StandoutNature
Multiplex messenger assay: simultaneous, quantitative measurement of expression of many genes in the context of T cell activation
1996
Development of Structural Complexity by Liquid‐Crystal Self‐assembly
2013
HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target
2008
Indoleamine 2,3‐dioxygenase contributes to tumor cell evasion of T cell‐mediated rejection
2002
The Epigenomics of Cancer
2007 Standout
Down-regulation of T cell receptors on self-reactive T cells as a novel mechanism for extrathymic tolerance induction
1991
Preferential positive selection of Vα2+CD8+ T cells in mouse strains expressing both H‐2k and T cell receptor Vαa haplotypes: determination with a Vα2‐specific monoclonal antibody
1992
Self‐Ignorance in the Peripheral T‐Cell Pool
1993
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
Nuclear factor-κB in cancer development and progression
2006 StandoutNature
CD4: Collaborator in immune recognition and HIV infection
1990 StandoutNobel
Trastuzumab — Mechanism of Action and Use in Clinical Practice
2007 Standout
Inflammatory cell infiltration of tumors: Jekyll or Hyde
2007
Graphene chiral liquid crystals and macroscopic assembled fibres
2011
Signal transduction by lymphocyte antigen receptors
1994 Standout
Emerging Solvent‐Induced Homochirality by the Confinement of Achiral Molecules Against a Solid Surface
2008 StandoutNobel
Two signaling pathways can lead to Fas ligand expression in CD8+ cytotoxic T lymphocyte clones
1995
T-cell antigen receptor genes and T-cell recognition
1988 StandoutNature
Adhesion receptors of the immune system
1990 StandoutNature
Autoimmune diabetes as a consequence of locally produced interleukin-2
1992 Nature
Cell-permeant caged InsP3 ester shows that Ca2+ spike frequency can optimize gene expression
1998 StandoutNatureNobel
Spontaneous resolution, whence and whither: from enantiomorphic solids to chiral liquid crystals, monolayers and macro- and supra-molecular polymers and assemblies
2007
The blockade of immune checkpoints in cancer immunotherapy
2012 Standout
Thymic selection in CD8 transgenic mice supports an instructive model for commitment to a CD4 or CD8 lineage
1991 StandoutNobel
The Fas Death Factor
1995 StandoutScience
Focal expression of interleukin-2 does not break unresponsiveness to "self" (viral) antigen expressed in beta cells but enhances development of autoimmune disease (diabetes) after initiation of an anti-self immune response.
1995 StandoutNobel
Global, In Vivo, and Site-Specific Phosphorylation Dynamics in Signaling Networks
2006 Standout
True
2000
Tumor necrosis factor or tumor promoting factor?
2002
Inability of CD8α′polypeptides to associate with p56lck correlates with impaired function in vitro and lack of expression in vivo
1989 Nature
Cancer-related inflammation
2008 StandoutNature
Crystal structure of a soluble form of the human T cell coreceptor CD8 at 2.6 Å resolution
1992 StandoutNobel
Tumour necrosis factor α: a potential target for the therapy of solid tumours
2003
The balance between deletion and activation of CD4+8+ thymocytes is controlled by T cell receptor‐antigen interactions and is affected by cyclosporin A
1994
CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
2011 StandoutNature
Molecular mechanisms underlying endocytosis and sorting of ErbB receptor tyrosine kinases
2001
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
2016 Standout
Cancer of the Ovary
2004 Standout
T cell receptor‐induced Fas ligand expression in cytotoxic T lymphocyte clones is blocked by protein tyrosine kinase inhibitors and cyclosporin A
1994
Thymocyte development is normal in CTLA-4-deficient mice
1997 StandoutNobel
Fluorescent indicators for cytosolic calcium based on rhodamine and fluorescein chromophores
1989 StandoutNobel
Naturally Arising CD4+Regulatory T Cells for Immunologic Self -Tolerance and Negative Control of Immune Responses
2003 StandoutNobel
Proteasome regulation of activation-induced T cell death
1997 StandoutNobel
Expression of CD4 in transgenic mice alters the specificity of CD8 cells for allogeneic major histocompatibility complex.
1991 StandoutNobel
Tolerance induction by thymic medullary epithelium.
1992 StandoutNobel
Supramolecular Double-Helix Formation by Diastereoisomeric Conformations of Configurationally Enantiomeric Macrocycles
2016 StandoutNobel
Glutamate Induces Calcium Waves in Cultured Astrocytes: Long-Range Glial Signaling
1990 StandoutScience
Reconstitution of MHC class I specificity by transfer of the T cell receptor and Lyt-2 genes
1987
Clonal Deletion Versus Clonal Anergy: The Role of the Thymus in Inducing Self Tolerance
1990 StandoutScienceNobel
Prognostic value of human kallikrein 10 expression in epithelial ovarian carcinoma.
2001
Deletion of high-avidity T cells by thymic epithelium.
1995
Inflammation, a Key Event in Cancer Development
2006
Pleiotropic loss of activation pathways in a T-cell receptor α-chain deletion variant of a cytolytic T-cell clone
1987 StandoutNatureNobel
Expression profiling with arrays of randomly disrupted genes in mouse embryonic stem cells leads to in vivo functional analysis
2004 StandoutNobel
Non‐Deletional Mechanisms of Peripheral and Central Tolerance: Studies with Transgenic Mice with Tissue‐Specific Expression of a Foreign MHC Class I Antigen
1991
Study of Etanercept, a Tumor Necrosis Factor-Alpha Inhibitor, in Recurrent Ovarian Cancer
2005
Normal Development of Mice Deficient in β 2 M, MCClass I Proteins, and CD8 + T Cells
1990 StandoutScienceNobel
von Hippel-Lindau Protein-Mediated Repression of Tumor Necrosis Factor Alpha Translation Revealed through Use of cDNA Arrays
2003
Ca2+ Oscillations Induced by Hormonal Stimulation of Individual Fura-2-loaded Hepatocytes
1989 StandoutNobel
Sequential activation and lethal hit measured by [Ca2+]i in individual cytolytic T cells and targets.
1987 StandoutNobel
Photochemically generated cytosolic calcium pulses and their detection by fluo-3
1989 StandoutNobel
Tumor Necrosis Factor-α Stimulates the Epithelial-to-Mesenchymal Transition of Human Colonic Organoids
2003
Generation of Calcium Oscillations in Fibroblasts by Positive Feedback Between Calcium and IP 3
1991 StandoutScienceNobel
The Halogen Bond
2016 Standout
Itk Negatively Regulates Induction of T Cell Proliferation by CD28 Costimulation
1997 StandoutNobel
Recent Advances in Ultrathin Two-Dimensional Nanomaterials
2017 Standout
Direct Carbonization of Al-Based Porous Coordination Polymer for Synthesis of Nanoporous Carbon
2012 StandoutNobel
Challenges and breakthroughs in recent research on self-assembly
2008
Expression of monocyte chemotactic protein-1 in human invasive ductal breast cancer
1998
Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4
2013 StandoutNobel
Constitutive class I-restricted exogenous presentation of self antigens in vivo.
1996 StandoutNobel
Locking of Helicity and Shape Complementarity in Diarylethene Dimers on Graphite
2007 StandoutNobel
Works of C. Boyer being referenced
Heregulin and agonistic anti-p185(c-erbB2) antibodies inhibit proliferation but increase invasiveness of breast cancer cells that overexpress p185(c-erbB2): increased invasiveness may contribute to poor prognosis.
1997
Requirements for the internalization of a murine monoclonal antibody directed against the HER-2/neu gene product c-erbB-2.
1991
Expression and amplification of the HER-2/ neu (c-erbB-2) protooncogene in epithelial ovarian tumors and cell lines
1991
Serum levels of HER-2neu (C-erbB-2) correlate with overexpression of p185neu in human ovarian cancer
1993
OVX1 radioimmunoassay complements CA-125 for predicting the presence of residual ovarian carcinoma at second-look surgical surveillance procedures.
1993
The Vesosome - A Multicompartment Drug Delivery Vehicle
2004
Transfection of Ovarian Cancer Cells with Tumor Necrosis Factor-α (TNF-α) Antisense mRNA Abolishes the Proliferative Response to Interleukin-1 (IL-1) but Not TNF-α
1994
Monoclonal antibodies against an H-2Kb-specific cytotoxic T cell clone detect several clone-specific molecules.
1986
Giant-block twist grain boundary smectic phases
2005
Polarization-Modulated Smectic Liquid Crystal Phases
2003 Science
Analysis of T cell activation requirements with the use of alloantigens or an anti-clonotypic monoclonal antibody.
1986
Tumor necrosis factor alpha as an autocrine and paracrine growth factor for ovarian cancer: monokine induction of tumor cell proliferation and tumor necrosis factor alpha expression.
1993